Table 2.
Hospitalization period and 12‐months major cardiac adverse event rate
| NSTEMI | ||||
|---|---|---|---|---|
| STEMI (n = 322) | N‐NSTEMI (n = 232) | non N‐NSTEMI (n = 320) | P value (all groups) | |
| All MACEs | 36 (11.2%) | 27 (11.6%) | 9 (2.8%) | .000 |
| In‐hospital MACEs (n, %) | ||||
| Number of patients (n) | 322 | 232 | 320 | |
| ST | 1 (0.3%) | 1 (0.4%) | 0 | .087 |
| TVR | 1 (0.3%) | 1 (0.4%) | 0 | .087 |
| TLR | 0 | 0 | 0 | ‐ |
| All‐cause death | 4 (1.2%) | 3 (1.2%) | 1 (0.3%) | .003 |
| Cardiogenic shock | 3 (0.9%) | 2 (0.8%) | 1 (0.3%) | .057 |
| Congestive heart failure | 2 (0.6%) | 2 (0.8%) | 1 (0.3%) | .081 |
| Cerebral ischemic stroke | 0 | 0 | 0 | ‐ |
| 12‐Months MACEs (n, %) | ||||
| Number of patients (n) | 315 | 230 | 310 | |
| ST | 3 (0.9%) | 2 (0.9%) | 0 | .002 |
| TVR | 5 (1.6%) | 4 (1.8%) | 1 (0.3%) | .000 |
| TLR | 3 (0.9%) | 3 (1.3%) | 2 (0.6%) | .145 |
| All‐cause death | 4 (1.2%) | 3 (1.3%) | 1 (0.3%) | .001 |
| Recurrent UAP | 4 (1.2%) | 4 (1.8%) | 1 (0.3%) | .000 |
| Congestive heart failure | 3 (0.9%) | 2 (0.9%) | 1 (0.3%) | .072 |
| Cerebral ischemic stroke | 1 (0.3%) | 0 | 0 | .155 |
Abbreviations: MACE, major adverse cardiac events; N‐NSTEMI, “N” wave non‐ST‐elevated myocardial infarction; non N‐NSTEMI, non‐“N”‐wave non‐ST‐elevated myocardial infarction; STEMI, ST‐elevated myocardial infarction, ST, stent thrombosis; TVR, target vessel revascularization; TLR, target lesion revascularization; UAP, unstable angina pectoris.